The New England Journal of Medicine has published a detailed analysis of Genentech’s positive results from the Phase III REGENCY study of Gazyva® (Obinutuzumab) for people with active lupus nephritis ...

In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...

Serving north, central and west Texas, including Dallas/Fort Worth, San Antonio, Austin, El Paso, Lubbock, and surrounding areas Join us for the 2025 Portland Lupus & You Empowerment Conference! Lupus ...

Serving north, central and west Texas, including Dallas/Fort Worth, San Antonio, Austin, El Paso, Lubbock, and surrounding areas Join us for the 2025 Seattle Lupus & You Empowerment Conference! Lupus ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

The Patient-Physician Dialogue Tool (PDF) is a guide to support people going through the process of diagnosis. It includes a checklist and some pointers on questions to ask to make the most of your ...

With a series of Instagram posts in September 2017, Selena Gomez shared that she’d undergone a kidney transplant at just 24, due to lupus-related organ damage. The announcement sent a shock wave ...

The history of lupus can be divided into three periods: classical, neoclassical, and modern. This article concentrates on developments in the present century which have greatly expanded our knowledge ...

Your part of the country is covered by the National Office. Below you’ll find some of the many ways you can find resources, get involved and turn your community into a local force fighting lupus! The ...

Annually, we detail our impact as we move ever closer to cure lupus and bring relief and help to millions. We take seriously our responsibility to the lupus community. Our mission is to END LUPUS. Now ...